{"id":113983,"title":"FTSE 100 reaches new high following takeover bid for Anglo American","publisher":"Share Talk","author":"sharetalk","published":"2024-04-25T07:42:46+00:00","modified":"2024-04-25T07:44:04+00:00","canonical_url":"https://www.share-talk.com/ftse-100-reaches-new-high-following-takeover-bid-for-anglo-american/","markdown_url":"https://www.share-talk.com/ftse-100-reaches-new-high-following-takeover-bid-for-anglo-american.md","json_url":"https://www.share-talk.com/ftse-100-reaches-new-high-following-takeover-bid-for-anglo-american.json","category":"B2B","categories":["B2B","Blogs","Business & Support Services","Technology","Technology, Media & Telecoms"],"tags":["Anglo American","AstraZeneca","Barclays","BHP Group","COPPER","FTSE 100","London","miner","Unilever"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/FTSE-100-15-NOV-23.jpg?fit=1200%2C800&quality=89&ssl=1","format":"news","language":"en-GB","content":"The FTSE 100 reached a new record high following a significant jump in Anglo American shares, spurred by a [takeover proposal](https://www.telegraph.co.uk/business/2024/04/25/bhp-plots-takeover-of-rival-mining-giant-anglo-american/) from BHP Group.\n\nAnglo American’s shares climbed 12.7% to a nine-month peak after BHP announced its intention to acquire the London-listed miner, placing its value at £31.1 billion.\n\nThis acquisition would position the combined entity as the largest copper miner globally, controlling about 10% of the worldwide production. Despite this, BHP’s UK-listed shares dropped by 3.7%.\n\nhttps://twitter.com/Share_Talk/status/1783399894864085455\n\nAdditionally, the FTSE 350 industrial metal miners index increased by 2.9%, and the elite FTSE 100 index rose by 0.7% to a new high of 8,098.14, while the mid-cap FTSE 250 declined by 0.6%.\n\nIn other market movements, AstraZeneca’s shares surged 5.7% after the pharmaceutical company reported quarterly revenues and profits that exceeded market expectations, driven by strong demand for its oncology and rare blood disorder treatments.\n\nUnilever also saw a boost, with shares up 4.1% following a report of first-quarter sales growth of 4.4%, surpassing forecasts as it regained customers who had previously shifted to less expensive alternatives.\n\nBarclays shares increased by 3.1% even though it reported a 12% decrease in first-quarter profits."}